Form 4: Molina Healthcare CEO Joseph Zubretsky Sells Shares Worth Millions

Molina Healthcare's CEO, Joseph M. Zubretsky, executed transactions involving the company's common stock, including sales and a trust transfer, as detailed in a recent SEC filing.

Summary

• Joseph M. Zubretsky, the President & CEO of Molina Healthcare, Inc., filed a Form 4 with the SEC detailing changes in his beneficial ownership of the company's stock.
• On April 30, 2025, Zubretsky sold 86,400 shares of common stock at $320 per share and 1,100 shares at a weighted average price of $324.7, with prices ranging from $324.22 to $324.84.
• Following these transactions, Zubretsky directly owns 41,195 shares and indirectly owns 257,715 shares held by the Joseph M. Zubretsky Revocable Trust.
• The filing also reflects a transfer of 345,215 shares of common stock to the Joseph M. Zubretsky Revocable Trust, which was exempt from reporting.
• The filing includes a Limited Power of Attorney, effective October 9, 2017, granting Jeff D. Barlow and Codruta Boggs the authority to execute and file Forms 3, 4, and 5 on Zubretsky's behalf.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but the market's interpretation of the CEO's stock sale could influence sentiment.

Industry Context

Executive stock transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Large sales may sometimes raise concerns, while purchases can signal confidence.

Stakeholder Impact

• Shareholders may react to the CEO's stock sale, potentially impacting the stock price.
• The CEO's actions could influence investor confidence in the company.

Key Dates

Keywords

Molina Healthcare, Joseph Zubretsky, SEC Form 4, Stock Sale, Beneficial Ownership, Equity Securities, Power of Attorney